0001209191-19-005455.txt : 20190125 0001209191-19-005455.hdr.sgml : 20190125 20190125212752 ACCESSION NUMBER: 0001209191-19-005455 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190124 FILED AS OF DATE: 20190125 DATE AS OF CHANGE: 20190125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAIDA ANTHONY E III CENTRAL INDEX KEY: 0001273213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 19543738 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DR CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-24 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001273213 MAIDA ANTHONY E III 11500 S. EASTERN AVE. SUITE 240 HENDERSON NV 89052 1 0 0 0 Common Stock, $0.001 par value 2019-01-24 4 M 0 1550 3.92 A 34538 D Common Stock, $0.001 par value 2019-01-24 4 S 0 1550 10.37 D 32988 D Common Stock, $0.001 par value 2019-01-24 4 M 0 5700 5.05 A 38688 D Common Stock, $0.001 par value 2019-01-24 4 S 0 5700 10.37 D 32988 D Stock Option Exercise (Right to Buy) 3.92 2019-01-24 4 M 0 1550 0.00 D 2020-07-01 Common Stock 1550 0 D Stock Option Exercise (Right to Buy) 5.05 2019-01-24 4 M 0 5700 0.00 D 2010-06-18 2020-04-20 Common Stock 5700 24300 D All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018. The stock option, representing the right to purchase a total of 30,000 shares of common stock, was granted on July 1, 2010. The stock option became exercisable as to 7,500 shares on July 1, 2010, 7,500 shares on July 1, 2011, 7,500 shares on July 1, 2012 and 7,500 shares on July 1, 2013. /s/ Kurt A. Gustafson, attorney-in-fact for Anthony E. Maida 2019-01-25